Related Experiment Video

Updated: Aug 23, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Invasive pneumococcal infections among hospitalized children in Bamako, Mali

James D Campbell1, Karen L Kotloff, Samba O Sow

  • 1University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD 21201, USA. jcampbel@medicine.umaryland.edu

The Pediatric Infectious Disease Journal
|July 13, 2004
PubMed

Insights

Invasive pneumococcal disease (IPD) is common and fatal in Malian children, with serotypes 5 and 2 predominating. Most circulating serotypes are covered by the 11-valent pneumococcal conjugate vaccine, offering a promising prevention strategy.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Invasive pneumococcal disease (IPD) prevention in children is a global health priority.
  • Identifying common serotypes is vital for effective vaccine strategies.

Purpose of the Study:

  • To determine the incidence, serotype distribution, and antimicrobial susceptibility of IPD in hospitalized children in Bamako, Mali.
  • To inform vaccine development and public health interventions.

Main Methods:

  • Prospective surveillance of IPD in hospitalized children in Bamako, Mali.
  • Blood cultures and other site cultures were performed on suspected cases.
  • Pneumococcal isolates were identified, serotyped, and tested for antimicrobial susceptibility.

Main Results:

  • 106 cases of IPD were identified among 2,049 children, with the highest incidence in infants.
  • The overall IPD case fatality rate was 24%, with serotypes 5 (54%) and 2 (14%) being most common.
  • Low rates of penicillin non-susceptibility were observed; 91% of isolates were covered by the 11-valent pneumococcal conjugate vaccine.

Conclusions:

  • IPD poses a significant public health burden in Malian children, characterized by high fatality rates.
  • The limited antimicrobial resistance is encouraging, but serotype distribution highlights the need for targeted vaccination.
  • The 11-valent pneumococcal conjugate vaccine covers a substantial proportion of IPD-causing serotypes in this population.
Abstract

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...